Schedule 13G/A: Finepoint and Wagner disclose 21.15M QXO shares (3.2%)
Rhea-AI Filing Summary
Amendment No. 1 to a Schedule 13G discloses that Finepoint Capital LP and Herbert Wagner together report beneficial ownership of 21,152,868 shares of QXO, Inc. common stock, representing 3.2% of the outstanding shares based on a total of 670,333,358 shares outstanding after the issuer's offering. Finepoint states it is a registered investment adviser that holds these shares on behalf of affiliated funds and has shared voting and dispositive power over the reported shares; Herbert Wagner is identified as Finepoint's founder and Managing Partner and also reports the same shared powers. The filing is an amendment restating prior disclosures and confirms the ownership figures and classifications reported on the cover pages.
Positive
- None.
Negative
- None.
Insights
TL;DR: Finepoint and Herbert Wagner report a 3.2% shared stake (21.15M shares) in QXO, disclosed via a Schedule 13G/A.
The filing confirms that Finepoint Capital LP holds 21,152,868 shares with shared voting and dispositive power and that this position represents 3.2% of QXO's common stock on a 670,333,358 share base. As this is a Schedule 13G/A and the cover pages show shared—not sole—voting/dispositive authority, the filing indicates passive investment reporting under the applicable rules rather than an intent to influence control. The amendment restates prior disclosure and aligns ownership figures with the issuer's increased share count after the reported offering.
TL;DR: The amendment documents a passive, sub-5% aggregate holding with shared rights—routine disclosure without an apparent control agenda.
The statement identifies Finepoint as an investment adviser to funds that directly hold the securities and names Herbert Wagner as founder/Managing Partner with identical shared voting and dispositive powers over 21,152,868 shares. Because reported ownership is 3.2%, this remains below the threshold that commonly triggers control presumption; the filing structure and certifications indicate the position is held in the ordinary course of business and not for control purposes, per the signatory certification.
FAQ
Who filed this Schedule 13G/A for QXO, Inc. and what do they report?
Is the reported position presented as an attempt to influence control of QXO?
Who signed the Schedule 13G/A on behalf of Finepoint?
AI-generated analysis. How Rhea-AI works. Not financial advice.